About

Dr. Ahmed Elshabrawy is a prominent urologic oncologist whose research focuses on optimizing surgical outcomes for kidney and bladder cancers through the analysis of large-scale national databases. His major contributions center on evaluating the adoption and effectiveness of minimally invasive techniques, including robot-assisted and laparoscopic surgery. In a highly cited 2022 study (20 citations), Dr. Elshabrawy demonstrated that minimally invasive radical nephrectomy offers survival outcomes comparable to open surgery for stage I and II renal cell carcinoma, supporting a shift toward less invasive approaches. He also investigated the diffusion of robot-assisted radical cystectomy, revealing nationwide trends and a significant association with increased rates of continent urinary diversion—a finding that directly impacts patient quality of life after bladder cancer surgery. Additionally, his work analyzing predictors of open conversion during minimally invasive partial nephrectomy (9 citations) provides critical guidance for surgical decision-making. By leveraging the National Cancer Database, Dr. Elshabrawy’s research provides evidence-based insights that help shape modern urologic oncology practice.

Research Focus

Key Achievements

3
H-Index
3
Papers
39
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma
20 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: The University of Texas at San Antonio Health Science Center, The University of Texas Health Science Center at Houston

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago